Inhibiting ataxia telangiectasia and Rad3-related protein (ATR)
US10570119B2 · kind B2 · utility
2Cited by
3References
15Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 11, 2017 |
| Grant date | Feb 25, 2020 |
| Priority date | — |
| Expiry date | Jan 11, 2037 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P35/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Novel compounds inhibiting ATR protein kinase include compounds of formula (I) disclosed herein, as well as liposome formulations comprising ATR protein kinase inhibitor compounds. The compositions are useful for the treatment of cancer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.